Clinical Trials Logo

Clinical Trial Summary

Preventing hypoxemia is one of the major goal of studies for bronchoscopic sedation. Dexmedetomidine is a sedative agents via α2 adrenergic agonist, with little respiratory suppression. In the preset study, we evaluate the safety and feasibility of the Dexmedetomidine in the specific bronchoscopic procedure, endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration.


Clinical Trial Description

Patients undergoing flexible bronchoscopy (FB) experience procedure-related symptoms. Current guidelines of FB recommend sedation to all patients undergoing FB, except when there are contraindications. Propofol plus an opioid is the common combination used to improve patient tolerance and satisfaction during FB. However, controversy about combining propofol and opioids persists because of the risk of over-sedation and cardiopulmonary depression, especially for the time-consuming endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA). Similar with other published data, around 40% of hypoxemia event was observed during FB sedation in the investigators' hospital. Dexmedetomidine, is a sedative agents via α2 adrenergic agonist, with little respiratory suppression. It has been applied in patients with mechanical ventilation, undergoing gastroendoscopy and extracorporal shockwave lithotripsy. Little evidences are available for Dexmedetomidine in sedation for EBUS-TBNA. In this study, the investigators will evaluate the safety and feasibility of Dexmedetomidine for sedation of EBUS-TBNA comparing to Propofol for sedation of EBUS-TBNA. Generally, the FB sedation can divided into three parts: the induction (from starting sedative administration to insertion of bronchoscope); the maintenance ( from insertion of bronchoscope to its removal) and the recovery (from bronchoscope removal to patients gain consciousness). The primary endpoint is the proportion of patients with hypoxemia during maintenance of sedation. the investigators will also observe the other sedative outcomes, e.g. blood pressure, sedative drug dosing and patient tolerance and cooperation. The present study will also observe the association between brain perfusion and sedative outcomes via non-invasive monitor. Based on the unique pharmacokinetic property of Dexmedetomidine and the real-time brain perfusion monitor, Dexmedetomidine-based sedation may provide better safety profile for EBUS-TBNA than propofol and discover novel connection between sedative outcomes and brain perfusion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03521505
Study type Interventional
Source Chang Gung Memorial Hospital
Contact
Status Completed
Phase Phase 4
Start date May 11, 2018
Completion date January 22, 2020

See also
  Status Clinical Trial Phase
Terminated NCT03581474 - Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting N/A
Completed NCT03294213 - Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView
Completed NCT06116955 - The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy
Withdrawn NCT03613792 - Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy Phase 4
Completed NCT04016480 - HFNC During Bronchoscopy for Bronchoalveolar Lavage N/A
Recruiting NCT01100554 - Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy N/A
Completed NCT00861835 - Trial of Rapid On-Site Evaluation of Transbronchial Needle Aspirate (TBNA) N/A
Completed NCT05154916 - The Effect of Virtual Reality Based Relaxation Program on Patients to be Performed Bronchoscopy N/A
Completed NCT03086408 - Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy N/A
Active, not recruiting NCT04884061 - Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection
Completed NCT05875662 - Pulmonary Ventilation After Fiberoptic Bronchoscopy Using EIT
Completed NCT00684684 - Safety and Feasibility Study of the Chartis System Phase 1
Not yet recruiting NCT03856073 - The Training and Evaluate Effect on Clinical Airway Management for Novices. N/A
Not yet recruiting NCT03854760 - The Training and Evaluate Effect on Clinical Airway Management N/A
Recruiting NCT05912985 - Three Different Oxygenation Strategies in Bronchoscopy Procedures Under Sedation
Enrolling by invitation NCT05692362 - Measure Airway Compliance by Endobronchial Optical Coherence Tomography
Completed NCT03419546 - Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
Completed NCT03886454 - Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
Not yet recruiting NCT03983915 - Sedation Strategies for Therapeutic Bronchoscopy 2 N/A
Not yet recruiting NCT03983889 - Sedation Strategies for Diagnostic Bronchoscopy 2 N/A